Dr. Bhrigu Kumar Das


Guwahati Campus

Dr. Bhrigu Kumar Das

Assistant Professor


Accounting can be divided into several fields including financial accounting, management accounting, external auditing, tax accounting and cost accounting. Accounting information systems are designed to support accounting functions and related activities. Financial accounting focuses on the reporting of an organization’s financial information, including the preparation of financial statements, to the external users of the information, such as investors.

Currently, Professor John is focusing his research on individual investor behavior and company incentives to better understand how disclosure affects stock returns and to uncover possible mispricing. Nevertheless, John is conducting an new way of examination of analyst access to information, and he is investigating market reactions to natural issues and the impact that would occur on individual firms.


  • Bachelor of Pharmacy 2013Gauhati University
  • Master's of Pharmacy in Pharmacology 2015KLE University, Karnataka
  • Ph. D in Pharmaceutical Science 2022KLE University, Karnataka
  • PGDCR&PV in Clinical Research and Pharmacovigilance 2015 ICBio, CRO, Innovative Centre for Biosciences, Bangalore, India.


  • Das, B.K., 2022. Altered gut microbiota in hepatocellular carcinoma: Insights into the pathogenic mechanism and preclinical to clinical findings. APMIS. [Impact Factor: 3.428]
  • Das, B.K., K, Jayalakshmi, Gadad P.C., 2022. 1H-NMR-based serum metabolomic study to evaluate the effect of asarone and metformin on experimentally induced diabetic hepatocellular carcinoma in rats. Bull. National Res Centre. 46:164.
  • Das, B.K., Gadad P.C., 2021. Impact of diabetes on the increased risk of hepatic cancer: An updated review of biological aspects. Diabetes Epidemiol Manag. 4:100025
  • Das, B.K., Koti, B.C., Swamy, A.H.M.V., Gadad P.C., World Congress on Drug Discovery Development. J N Tata Auditorium, Indian Institute of Science, Bengaluru. Page no: 1, Nov, 2016
  • Kamaiah, J., Das, B.K., Gadad P.C., 24th Conference of National Magnetic Resonance Society. Department of Physics, IISER Mohali, Punjab, India. Page no: 66, Feb, 2018.
  • Kiba, A, Saha, D., Das, B.K., NMPB (Ministry of AYUSH) Govt. of India Sponsored National Conference. Nagaon, Assam, India. Page no: 93, Jan, 2022.
  • Das, B.K., 2014. An overview on Hirudotherapy/leech therapy. Indian Res. J. Pharm. Sci., 1:33-45
  • Das, B.K., 2015. A brief scenario of Dengue virus. Int. J. Curr. Res., 7: 12864-12873.
  • Singh, M.K., Das, B.K., Trivedi, R., 2016. In vivo evaluation of immunomodulatory potential of ferulic acid. Int. Res. J. Pharm., 7: 12-17
  • Singh, M.K., Das, B.K., Patidar, P., 2016. The effect of methanolic extract of Buchanania lanzan Spreng seeds on hematological indices. Indian J. Pharmacol., 48: 214-215. [Impact Factor: 2.83]
  • Das, B.K., Singh, M.K., Kulkarni, J.M., 2016. Potential gastroprotective medicinal plants: An overview. Int. Res. J. Pharm., 7: 8-14
  • Das, B.K., Kulkarni, J.M., 2016. The landscape of therapeutic cancer vaccine. Int. J. Pharm. Sci. Res.,7:514-519
  • Das, B.K., Koti, B.C., Gadad, P.C., 2016. Role of Lycopersicon esculentum in diethylnitrosamine-induced and phenobarbital-promoted hepatocellular carcinoma. Indian J. Health Sci., 9:147-52
  • Singh, M.K., Das, B.K., Choudhary, S., Gupta, D., Patil, U.K., 2018. Diabetes and hepatocellular carcinoma: A pathophysiological link and pharmacological management. Biomed. Pharmacother., 106: 991-1002. [Impact Factor: 7.41]
  • Das, B.K., Koti, B.C., Patil, S.B., Gadad, P.C., 2019. Effect of Lycopersicon esculentum (tomato) on membrane-bound ATPases against diethylnitrosamine (DEN) induced and phenobarbital (PB) promoted hepatocellular carcinoma (HCC) in rats. Asian J. Pharm. Pharmacol., 5: 565-571.
  • Krishna, R.J., Pandagale, A., Ronad, P.M., Honnalli, S.S., Das, B.K., Gadad, P.C., 2019. Synthesis and pharmacological evaluation of schiff bases of 7-amino-4-methyl coumarins as novel anti-inflammatory agents. Asian J. Pharm. Pharmacol., 5: 693-700.
  • Das, B.K., Swamy, A.H.M.V., Koti, B.C.,Gadad, P.C., 2019. Experimental evidence for use of Acorus calamus (asarone) for cancer chemoprevention. Heliyon. 5: e01585. [Impact Factor: 3.77]
  • Das, B.K., Choukimath S.M., Gadad, P.C., 2019. Asarone and metformin delays experimentally induced hepatocellular carcinoma in diabetic milieu. Life Sci., 230:10-8. [Impact Factor: 6.78]
  • Das, B.K., Gadad, P.C., 2020. Asarone and metformin modulates the oxidant-antioxidant imbalance on experimentally induced hepatocellular carcinoma during diabetic condition. Indian J. Pharm. Educ. Res., 54:1039-1045. [Impact Factor: 0.843]
  • Das, B.K., Knott, R.M., Gadad, P.C., 2021. Metformin and asarone inhibit HepG2 cell proliferation in a high glucose environment by regulating AMPK and Akt signaling pathway. Futur. J. Pharm. Sci., 7: 43.
  • Das, B.K., Saha, D, Gadad, P.C., 2021. In silico discovery of novel phytoconstituents of Diplazium esculentum Retz. against diabetes mellitus. Chemistry Africa. 4:1-12.

Award, Fellowship & Recognition

  • Full-time Ph.D. Research Scholar grant (of contingency and scholarship) from KLE University, Belgaum, Karnataka (2016-2019)
  • Received a fellowship from the AICTE, Government of India (August 2013 to July 2015) for qualifying for the Graduate Pharmacy Aptitude Test (GPAT) conducted by All India Council for Technical Education (AICTE)-2013.